FINWIRES · TerminalLIVE
FINWIRES

Legacy Gold Mines股价上涨30%，接近52周高点，此前该公司通过非经纪人私募融资筹集了1000万美元。

-- Legacy Gold Mines (LEGY.V) 周四股价上涨 30%，接近 52 周高点，此前该公司完成了此前宣布的 1000 万美元非经纪人私募配售。 该公司表示，此次发行包括以每股 0.30 美元的价格发行 3330 万股普通股。私募配售完成后，由 Wexford Capital LP 管理的基金合计持有约 15% 的已发行流通普通股。 所得款项将用于推进其位于爱达荷州奥罗格兰德矿区的 Baner 金矿项目的钻探和开发活动，以及业务拓展和一般行政开支。该公司已同意向佛罗里达州的 John Tumazos 发行 825,490 股普通股，占此次私募配售中由他介绍的认购者所售普通股的 3%。 该公司还确认，已完成根据其购买该矿产项目100%权益期权支付的第二笔款项。该期权的最终付款将于2027年4月到期，包括50万美元现金和20万份可购买普通股的认股权证。 Legacy Gold Mines公司同时正在寻求多伦多证券交易所创业板（TSXV）的批准，将此前于2024年10月向Champion Electric公司发行的20万份认股权证的有效期延长12个月。 在本次私募配售中，首席执行官Brian Hinchcliffe以13.56万美元的总价购入了45.2万股普通股，勘探副总裁兼公司董事Mike Sutton以10万美元的价格购入了33.3333万股普通股。 该股在多伦多证券交易所创业板 (TSXV) 最新上涨 0.14 美元至 0.60 美元，距离 52 周高点 0.63 美元仍有一定差距。

Price: $0.60, Change: $+0.14, Percent Change: +30.43%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB